Tenaya Therapeutics (NASDAQ:TNYA) Now Covered by Analysts at SVB Leerink

Research analysts at SVB Leerink started coverage on shares of Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) in a note issued to investors on Thursday, Marketbeat.com reports. The firm set an “outperform” rating and a $7.00 price target on the stock. SVB Leerink’s price objective suggests a potential upside of 255.33% from the stock’s current […]

Related Keywords

United States , ,Tower Research Capital ,Tenaya Therapeutics Company Profile ,Tenaya Therapeutics Inc ,Barclays Plc ,Balyasny Asset Management ,Capital Management ,Morgan Stanley ,Canaccord Genuity Group ,Tenaya Therapeutics ,Get Free Report ,Genuity Group ,Street Group ,Asset Management ,Research Capital ,Tenaya Therapeutics Daily ,Nasdaq Tnya ,Iatnya ,Medical ,Initiated Coverage ,Svb Leerink Llc ,